These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 12693936)

  • 1. Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs.
    Sivaraman S; Zwahlen J; Bell AF; Hedstrom L; Tonge PJ
    Biochemistry; 2003 Apr; 42(15):4406-13. PubMed ID: 12693936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene.
    Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA
    Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the bacterial enoyl reductase FabI by triclosan: a structure-reactivity analysis of FabI inhibition by triclosan analogues.
    Sivaraman S; Sullivan TJ; Johnson F; Novichenok P; Cui G; Simmerling C; Tonge PJ
    J Med Chem; 2004 Jan; 47(3):509-18. PubMed ID: 14736233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of inhibitor aliphatic chain in the thermodynamics of inhibitor binding to Escherichia coli enoyl-ACP reductase and the Phe203Leu mutant: a proposed mechanism for drug resistance.
    Protasevich II; Brouillette CG; Snow ME; Dunham S; Rubin JR; Gogliotti R; Siegel K
    Biochemistry; 2004 Oct; 43(42):13380-9. PubMed ID: 15491144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signature gene expression profile of triclosan-resistant Escherichia coli.
    Yu BJ; Kim JA; Pan JG
    J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors.
    Kapoor M; Dar MJ; Surolia A; Surolia N
    Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
    Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
    J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallographic analysis of triclosan bound to enoyl reductase.
    Roujeinikova A; Levy CW; Rowsell S; Sedelnikova S; Baker PJ; Minshull CA; Mistry A; Colls JG; Camble R; Stuitje AR; Slabas AR; Rafferty JB; Pauptit RA; Viner R; Rice DW
    J Mol Biol; 1999 Nov; 294(2):527-35. PubMed ID: 10610777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase.
    Levy CW; Baldock C; Wallace AJ; Sedelnikova S; Viner RC; Clough JM; Stuitje AR; Slabas AR; Rice DW; Rafferty JB
    J Mol Biol; 2001 May; 309(1):171-80. PubMed ID: 11491286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of triclosan inhibition of bacterial fatty acid synthesis.
    Heath RJ; Rubin JR; Holland DR; Zhang E; Snow ME; Rock CO
    J Biol Chem; 1999 Apr; 274(16):11110-4. PubMed ID: 10196195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The X-ray structure of Escherichia coli enoyl reductase with bound NAD+ at 2.1 A resolution.
    Baldock C; Rafferty JB; Stuitje AR; Slabas AR; Rice DW
    J Mol Biol; 1998 Dec; 284(5):1529-46. PubMed ID: 9878369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis and mechanism of enoyl reductase inhibition by triclosan.
    Stewart MJ; Parikh S; Xiao G; Tonge PJ; Kisker C
    J Mol Biol; 1999 Jul; 290(4):859-65. PubMed ID: 10398587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel enoyl-acyl carrier protein reductase of diazaborine-resistant Rhodobacter sphaeroides mutant.
    Lee IH; Kim EJ; Cho YH; Lee JK
    Biochem Biophys Res Commun; 2002 Dec; 299(4):621-7. PubMed ID: 12459184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan.
    Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW
    Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the triclosan-binding region of enoyl-ACP (acyl-carrier protein) reductase from Plasmodium falciparum.
    Kapoor M; Gopalakrishnapai J; Surolia N; Surolia A
    Biochem J; 2004 Aug; 381(Pt 3):735-41. PubMed ID: 15139852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis for triclosan activity involves a flipping loop in the active site.
    Qiu X; Janson CA; Court RI; Smyth MG; Payne DJ; Abdel-Meguid SS
    Protein Sci; 1999 Nov; 8(11):2529-32. PubMed ID: 10595560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
    Heath RJ; Su N; Murphy CK; Rock CO
    J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ucFabV Requires Functional Reductase Activity to Confer Reduced Triclosan Susceptibility in Escherichia coli.
    Fischer TL; White RJ; Mares KF; Molnau DE; Donato JJ
    J Mol Microbiol Biotechnol; 2015; 25(6):394-402. PubMed ID: 26683704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the interaction energies for the binding of hydroxydiphenyl ethers to enoyl-acyl carrier protein reductases.
    Muralidharan J; Suguna K; Surolia A; Surolia N
    J Biomol Struct Dyn; 2003 Feb; 20(4):589-94. PubMed ID: 12529157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.